Jane Street
INO icon

Jane Street’s Inovio Pharmaceuticals INO Stock Holding History

Jane Street’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8K Sell
11,400
-6,000
-34% -$9.88K ﹤0.01% 11194
2025
Q4 		$30.3K Sell
17,400
-22,300
-56% -$49.1K ﹤0.01% 10645
2025
Q3 		$92.9K Buy
+39,700
New +$76K ﹤0.01% 10168
2023
Q3 		– Sell
-900
Closed -$4.82K – 8975
2023
Q2 		$4.82K Sell
900
-7,033
-89% -$56.7K ﹤0.01% 8496
2023
Q1 		$78.1K Sell
7,933
-284
-3% -$4.84K ﹤0.01% 8329
2022
Q4 		$154K Sell
8,217
-1,658
-17% -$37.6K ﹤0.01% 7849
2022
Q3 		$204K Buy
9,875
+5,108
+107% +$131K ﹤0.01% 8148
2022
Q2 		$99K Sell
4,767
-1,550
-25% -$43.7K ﹤0.01% 8643
2022
Q1 		$272K Sell
6,317
-27,958
-82% -$1.26M ﹤0.01% 8544
2021
Q4 		$2.05M Sell
34,275
-6,267
-15% -$502K ﹤0.01% 4436
2021
Q3 		$3.48M Sell
40,542
-7,025
-15% -$705K ﹤0.01% 3381
2021
Q2 		$5.29M Sell
47,567
-14,450
-23% -$1.39M ﹤0.01% 2542
2021
Q1 		$6.91M Buy
62,017
+11,692
+23% +$1.54M ﹤0.01% 1970
2020
Q4 		$5.34M Sell
50,325
-190,617
-79% -$25.4M ﹤0.01% 2057
2020
Q3 		$33.5M Sell
240,942
-53,691
-18% -$11.2M 0.02% 534
2020
Q2 		$95.3M Buy
294,633
+201,458
+216% +$32.3M 0.07% 193
2020
Q1 		$8.32M Buy
+93,175
New +$5.74M 0.01% 861
2017
Q4 		– Sell
-867
Closed -$66K – 4860
2017
Q3 		$66K Sell
867
-283
-25% -$21.1K ﹤0.01% 4315
2017
Q2 		$108K Buy
+1,150
New +$98.4K ﹤0.01% 4151
2016
Q3 		– Sell
-1,117
Closed -$124K – 4252
2016
Q2 		$124K Buy
+1,117
New +$136K ﹤0.01% 3861

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's INO Position: Q1 2026 in Review

Jane Street reduced its Inovio Pharmaceuticals (INO) stake by 47% in Q1 2026, selling an estimated $45.6K and leaving 30,691 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #10951.

Jane Street first reported a position in INO in Q4 2013 and has held it in 37 quarters since. The position peaked at $23.3M in Q2 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Jane Street held 30,691 shares of Inovio Pharmaceuticals worth $53.4K as of Q1 2026.
  • Jane Street sold 27,698 Inovio Pharmaceuticals shares in Q1 2026, an estimated $45.6K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10951 holding.
  • Jane Street first reported a position in Inovio Pharmaceuticals in Q4 2013 and has held it in 37 quarters since.
  • Jane Street's Inovio Pharmaceuticals position peaked at $23.3M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.